Literature DB >> 21454711

Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions.

Yanhong Zhang1, Wensheng Yan, Xinbin Chen.   

Abstract

Mutant p53 is not only deficient in tumor suppression but also acquires additional activity, called gain of function. Mutant p53 gain of function is recapitulated in knock-in mice that carry one null allele and one mutant allele of the p53 gene. These knock-in mice develop aggressive tumors compared with p53-null mice. Recently, we and others showed that tumor cells carrying a mutant p53 are addicted to the mutant for cell survival and resistance to DNA damage. To further define mutant p53 gain of function, we used the MCF-10A three-dimensional model of mammary morphogenesis. MCF-10A cells in three-dimensional culture undergo a series of morphological changes and form polarized and growth-arrested spheroids with hollow lumen, which resembles normal glandular architectures in vivo. Here, we found that endogenous wild-type p53 in MCF-10A cells was not required for acinus formation, but knockdown of endogenous wild-type p53 (p53-KD) led to partial clearance of cells in the lumen due to decreased apoptosis. Consistent with this, p53-KD altered expression patterns of the cell adhesion molecule E-cadherin, the cytoskeletal marker β-catenin, and the extracellular matrix protein laminin V. We also found that ectopic expression of the mutant G245S led to a phenotype similar to p53-KD, whereas a combination of ectopic expression of siRNA-resistant G245S with p53-KD led to a less cleared lumen. In contrast, ectopic expression of mutant R248W, R175H, and R273H disrupted normal acinus architectures with filled lumen and led to formation of irregular and multiacinus structures regardless of p53-KD. In addition, these mutants altered normal expression patterns and/or levels of E-cadherin, β-catenin, laminin V, and tight junction marker ZO-1. Furthermore, epithelial-to-mesenchymal transitions (EMT) markers, Snail, Slug, and Twist, were highly induced by mutant p53 and/or p53-KD. Together, we postulate that EMT represents a mutant p53 gain of function and mutant p53 alters cell polarity via EMT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454711      PMCID: PMC3091229          DOI: 10.1074/jbc.M110.214585

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Cell polarity in eggs and epithelia: parallels and diversity.

Authors:  Daniel St Johnston; Julie Ahringer
Journal:  Cell       Date:  2010-05-28       Impact factor: 41.582

2.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.

Authors:  Valerie M Weaver; Sophie Lelièvre; Johnathon N Lakins; Micah A Chrenek; Jonathan C R Jones; Filippo Giancotti; Zena Werb; Mina J Bissell
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

3.  Characterization of functional domains necessary for mutant p53 gain of function.

Authors:  Wensheng Yan; Xinbin Chen
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

4.  ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini.

Authors:  S K Muthuswamy; D Li; S Lelievre; M J Bissell; J S Brugge
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

5.  Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells.

Authors:  Rachel Sarig; Noa Rivlin; Ran Brosh; Chamutal Bornstein; Iris Kamer; Osnat Ezra; Alina Molchadsky; Naomi Goldfinger; Ori Brenner; Varda Rotter
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

6.  Chemosensitivity linked to p73 function.

Authors:  Meredith S Irwin; Keiichi Kondo; Maria Carmen Marin; Lynn S Cheng; William C Hahn; William G Kaelin
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

7.  Mutant p53 drives invasion by promoting integrin recycling.

Authors:  Patricia A J Muller; Patrick T Caswell; Brendan Doyle; Marcin P Iwanicki; Ee H Tan; Saadia Karim; Natalia Lukashchuk; David A Gillespie; Robert L Ludwig; Pauline Gosselin; Anne Cromer; Joan S Brugge; Owen J Sansom; Jim C Norman; Karen H Vousden
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

Review 8.  Polarity proteins regulate mammalian cell-cell junctions and cancer pathogenesis.

Authors:  Michael E Feigin; Senthil K Muthuswamy
Journal:  Curr Opin Cell Biol       Date:  2009-09-02       Impact factor: 8.382

9.  p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

Authors:  Chun-Ju Chang; Chi-Hong Chao; Weiya Xia; Jer-Yen Yang; Yan Xiong; Chia-Wei Li; Wen-Hsuan Yu; Sumaiyah K Rehman; Jennifer L Hsu; Heng-Huan Lee; Mo Liu; Chun-Te Chen; Dihua Yu; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2011-02-20       Impact factor: 28.824

10.  Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis.

Authors:  V L Seewaldt; K Mrózek; R Sigle; E C Dietze; K Heine; D M Hockenbery; K B Hobbs; L E Caldwell
Journal:  J Cell Biol       Date:  2001-10-22       Impact factor: 10.539

View more
  46 in total

1.  Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition.

Authors:  Yanhong Zhang; Wensheng Yan; Yong Sam Jung; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

2.  Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.

Authors:  William A Freed-Pastor; Hideaki Mizuno; Xi Zhao; Anita Langerød; Sung-Hwan Moon; Ruth Rodriguez-Barrueco; Anthony Barsotti; Agustin Chicas; Wencheng Li; Alla Polotskaia; Mina J Bissell; Timothy F Osborne; Bin Tian; Scott W Lowe; Jose M Silva; Anne-Lise Børresen-Dale; Arnold J Levine; Jill Bargonetti; Carol Prives
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

3.  Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.

Authors:  Shengliang Zhang; Lanlan Zhou; Bo Hong; A Pieter J van den Heuvel; Varun V Prabhu; Noel A Warfel; Christina Leah B Kline; David T Dicker; Levy Kopelovich; Wafik S El-Deiry
Journal:  Cancer Res       Date:  2015-08-20       Impact factor: 12.701

Review 4.  DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity.

Authors:  Nanyue Chen; Seetharaman Balasenthil; Jacquelyn Reuther; Ann McNeill Killary
Journal:  Cancer Res       Date:  2014-09-26       Impact factor: 12.701

5.  Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.

Authors:  Marcin P Iwanicki; Hsing-Yu Chen; Claudia Iavarone; Ioannis K Zervantonakis; Taru Muranen; Marián Novak; Tan A Ince; Ronny Drapkin; Joan S Brugge
Journal:  JCI Insight       Date:  2016-07-07

6.  Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis.

Authors:  Marco M Candeias; Masatoshi Hagiwara; Michiyuki Matsuda
Journal:  EMBO Rep       Date:  2016-10-04       Impact factor: 8.807

7.  P63 regulates tubular formation via epithelial-to-mesenchymal transition.

Authors:  Y Zhang; W Yan; X Chen
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

Review 8.  Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion.

Authors:  Patricia J Keely
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-07       Impact factor: 2.673

9.  The role of miR-200a in mammalian epithelial cell transformation.

Authors:  Lindsey E Becker; Apana Agha L Takwi; Zhongxin Lu; Yong Li
Journal:  Carcinogenesis       Date:  2014-09-19       Impact factor: 4.944

10.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.